MAP3K7 and prostate cancer: For instance, in prostate cancer MAP3K7 deletion is associated with an advanced tumor stage, lymph node metastasis and an early biochemical recurrence [16, 27], and suppression of MAP3K7 has been shown to promote tumorigenesis [28].